{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:05:13Z","timestamp":1792188313399,"version":"4.4.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s42000-025-00681-z","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:43:29Z","timestamp":1748918609000},"page":"905-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnosis and management of primary hyperparathyroidism: recommendations from the Bone Section of the Hellenic Endocrine Society"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-6296","authenticated-orcid":false,"given":"Athanasios D.","family":"Anastasilakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Yavropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Kassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotini","family":"Adamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Vryonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Symeon","family":"Tournis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polyzois","family":"Makras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"681_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s42000-020-00195-w","volume":"19","author":"P Makras","year":"2020","unstructured":"Makras P, Yavropoulou MP, Kassi E et al (2020) Management of parathyroid disorders: recommendations of the working group of the bone section of the Hellenic endocrine society. Horm (Athens) 19:581\u2013591. https:\/\/doi.org\/10.1007\/s42000-020-00195-w","journal-title":"Horm (Athens)"},{"key":"681_CR2","doi-asserted-by":"publisher","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ et al (2022) Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Min Res 37:2293\u20132314. https:\/\/doi.org\/10.1002\/jbmr.4677","DOI":"10.1002\/jbmr.4677"},{"issue":"63","key":"681_CR3","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1044","volume":"186","author":"J Bollerslev","year":"2022","unstructured":"Bollerslev J, Rejnmark L, Zahn A et al (2022) European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders. Eur J Endocrinol 186(63):R33\u2013R. https:\/\/doi.org\/10.1530\/EJE-21-1044","journal-title":"Eur J Endocrinol"},{"key":"681_CR4","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1681\/ASN.2007040449","volume":"19","author":"C Gauci","year":"2008","unstructured":"Gauci C, Moranne O, Fouqueray B et al (2008) Pitfalls of measuring total blood calcium in patients with CKD. J Am Soc Nephrol 19:1592\u20131598. https:\/\/doi.org\/10.1681\/ASN.2007040449","journal-title":"J Am Soc Nephrol"},{"key":"681_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.chest.2015.12.001","volume":"149","author":"SK Aberegg","year":"2016","unstructured":"Aberegg SK (2016) Ionized calcium in the ICU: should it be measured and corrected?? Chest 149:846\u2013855. https:\/\/doi.org\/10.1016\/j.chest.2015.12.001","journal-title":"Chest"},{"key":"681_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ecl.2021.07.001","volume":"50","author":"F Cetani","year":"2021","unstructured":"Cetani F, Pardi E, Marcocci C (2021) Parathyroid carcinoma and ectopic secretion of parathyroid hormone. Endocrinol Metab Clin North Am 50:683\u2013709. https:\/\/doi.org\/10.1016\/j.ecl.2021.07.001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"681_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s42000-018-0069-6","volume":"18","author":"DA Anastasilakis","year":"2019","unstructured":"Anastasilakis DA, Makras P, Polyzos SA, Anastasilakis AD, Part of the CET: (2019) Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview. Horm (Athens) 18:65\u201370. https:\/\/doi.org\/10.1007\/s42000-018-0069-6","journal-title":"Horm (Athens)"},{"key":"681_CR8","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1210\/clinem\/dgae162","volume":"109","author":"C Halimi","year":"2024","unstructured":"Halimi C, Bor C, Chieze R et al (2024) Comparison of normocalcemic vs hypercalcemic primary hyperparathyroidism in a hypercalciuric renal stone population. J Clin Endocrinol Metab 109:2553\u20132560. https:\/\/doi.org\/10.1210\/clinem\/dgae162","journal-title":"J Clin Endocrinol Metab"},{"key":"681_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.metabol.2017.10.003","volume":"80","author":"P Makras","year":"2018","unstructured":"Makras P, Anastasilakis AD (2018) Bone disease in primary hyperparathyroidism. Metabolism 80:57\u201365. https:\/\/doi.org\/10.1016\/j.metabol.2017.10.003","journal-title":"Metabolism"},{"key":"681_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s11154-024-09899-5","volume":"25","author":"A Palermo","year":"2024","unstructured":"Palermo A, Tabacco G, Makras P et al (2024) Primary hyperparathyroidism: from guidelines to outpatient clinic. Rev Endocr Metab Disord 25:875\u2013896. https:\/\/doi.org\/10.1007\/s11154-024-09899-5","journal-title":"Rev Endocr Metab Disord"},{"key":"681_CR11","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1210\/clinem\/dgac734","volume":"108","author":"NM Appelman-Dijkstra","year":"2023","unstructured":"Appelman-Dijkstra NM, Pilz S (2023) Approach to the patient: management of parathyroid diseases across pregnancy. J Clin Endocrinol Metab 108:1505\u20131513. https:\/\/doi.org\/10.1210\/clinem\/dgac734","journal-title":"J Clin Endocrinol Metab"},{"key":"681_CR12","doi-asserted-by":"publisher","unstructured":"Tsourdi E, Anastasilakis AD (2021) Parathyroid disease in pregnancy and lactation: A narrative review of the literature. Biomedicines 9. https:\/\/doi.org\/10.3390\/biomedicines9050475","DOI":"10.3390\/biomedicines9050475"},{"key":"681_CR13","unstructured":"https:\/\/www.google.gr\/url?sa=t&source=web&rct=j&opi=89978449&https:\/\/www.moh.gov.gr\/articles\/health\/dieythynsh-prwtobathmias-frontidas-ygeias\/draseis-kai-programmata-agwghs-ygeias\/oikogeneiakos-programmatismos\/5256-paidiatrikes-kateythynthries-odhgies%3Ffdl%3D12799%26ved=2ahUKEwjAzO-GlsCLAxXB0AIHHf5kJikQFnoECCwQAQ%26usg=AOvVaw03Z7DVMZdk7EDkjM6PjmJP"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-025-00681-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-025-00681-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-025-00681-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T05:32:43Z","timestamp":1764826363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-025-00681-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["681"],"URL":"https:\/\/doi.org\/10.1007\/s42000-025-00681-z","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable for this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"ADA reports fees for lectures\/advisory boards from Amgen, Bianex, Eli-Lilly, Er-Kim, Galenica, ITF, Uni-pharma, and UCB; MPY reports fees for lectures\/advisory boards from Amgen, Er-Kim, Galenica, Genesis, and UCB; EK reports fees for lectures\/advisory boards from Amgen, AstraZeneca, Er-Kim, and UCB; FA reports fees for lectures\/advisory boards from Amgen, Er-Kim, and Kyowa Kirin; AV has nothing to declare; ST reports fees for lectures\/advisory boards from Amgen, AstraZeneca, Elpen, Er-Kim, Genesis and UCB; PM reports research grants from Amgen and Galenica and fees for lectures\/advisory boards from UCB, Elpen, Bianex, Eli-Lilly.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest in respect to the article"}}]}}